Clinical Trials
3
Active:0
Completed:3
Trial Phases
1 Phases
Phase 2:3
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (3 trials with phase data)• Click on a phase to view related trials
Phase 2
3 (100.0%)Safety and Efficacy Study of 10XB-101 in Adults With Bilateral Flank Adiposity
Phase 2
Completed
- Conditions
- Subcutaneous Fat Disorder
- Interventions
- Drug: 10XB-101 Solution for Injection, 6.0%Drug: Placebo Solution for Injection (no active ingredient)
- First Posted Date
- 2023-03-08
- Last Posted Date
- 2025-06-29
- Lead Sponsor
- 10xBio, LLC
- Target Recruit Count
- 13
- Registration Number
- NCT05760248
- Locations
- 🇺🇸
Site #01, Rolling Meadows, Illinois, United States
🇺🇸Site #02, New Brighton, Minnesota, United States
A Safety and Tolerability Study of 10XB-101 Injection in Adult Subjects With Submental Fat
Phase 2
Completed
- Conditions
- Submental Fat
- Interventions
- Drug: 10XB-101 Vehicle Solution for InjectionDrug: 10XB-101 Solution for Injection
- First Posted Date
- 2021-12-13
- Last Posted Date
- 2025-06-29
- Lead Sponsor
- 10xBio, LLC
- Target Recruit Count
- 51
- Registration Number
- NCT05154955
- Locations
- 🇺🇸
Site 03, Encino, California, United States
🇺🇸Site 02, San Diego, California, United States
🇺🇸Site 01, San Diego, California, United States
A Safety and Tolerability Study of 10XB-101 Injections in Adult Subjects With Extra Fat Under the Chin ("Double Chin")
Phase 2
Completed
- Conditions
- Submental Fat
- Interventions
- Drug: 10XB-101 Solution for Injection
- First Posted Date
- 2020-02-06
- Last Posted Date
- 2024-04-10
- Lead Sponsor
- 10xBio, LLC
- Target Recruit Count
- 15
- Registration Number
- NCT04258761
- Locations
- 🇺🇸
Site 01, San Diego, California, United States
News
No news found